The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Morabito Christopher since 2021.
This trader's CIK number is 1859284.
At the time of last reporting, Morabito Christopher was the Chief Medical Officer of Astria Therapeutics, Inc.. (stock ticker symbol ATXS).
Also see all insider trading activities at Astria Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | FULC | 1,100 | $10,076 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ATXS | 0 | $0 | 20,000 | $247,304 | 20,000 | $77,400 |
1. Fulcrum Therapeutics, Inc. (FULC)
2. Astria Therapeutics, Inc. (ATXS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-28 | FULC | Buy | 1,100 | 9.16 | 10,076 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-04-01 | ATXS | Sale | 10,000 | 13.59 | 135,940 |
| 2024-04-01 | ATXS | Option Ex | 10,000 | 3.87 | 38,700 |
| 2024-01-26 | ATXS | Sale | 800 | 11.02 | 8,812 |
| 2024-01-26 | ATXS | Option Ex | 800 | 3.87 | 3,096 |
| 2024-01-29 | ATXS | Sale | 9,200 | 11.15 | 102,552 |
| 2024-01-29 | ATXS | Option Ex | 9,200 | 3.87 | 35,604 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Morabito Christopher (Chief Medical Officer of Astria Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.